Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, and Ways and Means, for a period to be subsequently determined by the Speaker…
The Patients Over Profit Act would make it unlawful for the same person or entity to own, operate, or control both a health insurance issuer and an "applicable provider" (or a management services organization that contracts with such a provider).
Entities that are in violation must divest either the provider/management services organization or the insurer within statutory deadlines (1 year for post-enactment acquisitions, 2 years for pre-existing holdings), subject to tolling during merger review.
Enforcement may be pursued by the HHS Inspector General, DOJ Antitrust Division, the FTC, or state attorneys general via civil actions requiring divestiture and disgorgement of revenues; disgorged funds are to be distributed by the FTC for community health needs.
On content alone the bill is a bold, interventionist measure with substantial regulatory and market consequences. While it contains some transition provisions and exclusions that could facilitate compromise, its sweeping prohibition on insurer–provider common ownership and mandatory divestiture are likely to provoke strong opposition from powerful stakeholders and raise complex implementation, legal, and fiscal questions—factors that historically reduce the chance that such structural, high-cost reforms become enacted absent broad bipartisan buy-in or major bargaining tradeoffs.
Relative to its intended legislative type, this bill is a clearly-structured substantive policy measure: it creates a new statutory prohibition, prescribes remedies and timelines, integrates with existing antitrust and Medicare law, and assigns enforcement roles. It provides detailed statutory mechanics but delegates several operational specifics to agency rulemaking.
Whether vertical integration primarily creates harmful conflicts of interest (progressives emphasize) or whether it often improves coordination and efficiency (conservatives emphasize).
Whether vertical integration primarily creates harmful conflicts of interest (progressives emphasize) or whether it often improves coordination and efficiency (conservatives emphasize).
A mainstream progressive would likely view the bill favorably as a measure to separate insurer profit incentives from patient care and reduce conflicts of interest created by vertical integration.
They would see the divestiture requirement, civil enforcement tools, and FTC review as concrete mechanisms to curb anti-competitive or patient-harming behavior by vertically integrated health-finance firms.
They may have some caution about potential short-term disruptions to care or worker impacts during divestitures, but would likely prioritize the bill’s aim to prioritize patient welfare over corporate consolidation.
A pragmatic moderate would see legitimate reasons for the bill — reducing perverse incentives and potential anti-competitive vertical integration — but would be concerned about operational details, transitional harms, and unintended consequences for care coordination.
They would weigh the consumer-protection and competition gains against the risk that forced structural separations could destabilize existing care delivery arrangements, particularly in Medicare Advantage, and increase costs or reduce access if not implemented carefully.
Overall, a centrist perspective would be cautiously open but seek amendments to clarify scope, timelines, and safeguards.
A mainstream conservative would likely oppose the bill as an overbroad federal intervention that interferes with private business structures and the contracts of insurers and providers.
They would view the mandatory structural separation as government overreach that could reduce investment in integrated care models, undermine efficiencies from vertical integration, and increase regulatory and compliance burdens.
They would also be concerned about the effect on Medicare Advantage contracting and potential disruptions to beneficiary access.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone the bill is a bold, interventionist measure with substantial regulatory and market consequences. While it contains some transition provisions and exclusions that could facilitate compromise, its sweeping prohibition on insurer–provider common ownership and mandatory divestiture are likely to provoke strong opposition from powerful stakeholders and raise complex implementation, legal, and fiscal questions—factors that historically reduce the chance that such structural, high-cost reforms become enacted absent broad bipartisan buy-in or major bargaining tradeoffs.
The bill has not accumulated any surfaced votes yet.
Whether vertical integration primarily creates harmful conflicts of interest (progressives emphasize) or whether it often improves coordina…
On content alone the bill is a bold, interventionist measure with substantial regulatory and market consequences. While it contains some tr…
Relative to its intended legislative type, this bill is a clearly-structured substantive policy measure: it creates a new statutory prohibition, prescribes remedies and timelines, integrates with existing antitrust and…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.